← All trials

NCT06061614

Early Phase 1Interventional

Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).

View on ClinicalTrials.gov ↗

Timeline

Start date
Mar 30, 2023
Primary completion
Dec 30, 2028
Completion date
Dec 30, 2028
First posted
Sep 29, 2023
Last posted
Sep 29, 2023
Enrollment
9
Arms / groups
3 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.